📣 VC round data is live. Check it out!

Telemedycyna Polska Valuation Multiples

Discover revenue and EBITDA valuation multiples for Telemedycyna Polska and similar public comparables like Aino Health, Andiamo, Monsenso, Medondo Holding and more.

Telemedycyna Polska Overview

About Telemedycyna Polska

Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.


Founded

2005

HQ

Poland

Employees

35

Financials (FY)

Revenue: $1M
EBITDA: ($319K)

EV

$3M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Telemedycyna Polska Financials

Telemedycyna Polska reported last fiscal year revenue of $1M and negative EBITDA of ($319K).

In the same fiscal year, Telemedycyna Polska generated $1M in gross profit, ($319K) in EBITDA losses, and had net loss of ($404K).


Telemedycyna Polska P&L

In the most recent fiscal year, Telemedycyna Polska reported revenue of $1M and EBITDA of ($319K).

Telemedycyna Polska is unprofitable as of last fiscal year, with gross margin of 92%, EBITDA margin of (22%), and net margin of (28%).

See analyst estimates for Telemedycyna Polska
Last FY202320242025202620272028
Revenue$1M$2M$1M$1M
Gross Profit$1M$2M$1M$1M
Gross Margin92%98%89%92%
EBITDA($319K)($19K)($564K)($319K)
EBITDA Margin(22%)(1%)(38%)(22%)
EBIT Margin(27%)(5%)(42%)(27%)
Net Profit($404K)($64K)($743K)($404K)
Net Margin(28%)(4%)(50%)(28%)

Financial data powered by Morningstar, Inc.

Telemedycyna Polska Stock Performance

Telemedycyna Polska has current market cap of $3M, and enterprise value of $3M.

Market Cap Evolution


Telemedycyna Polska's stock price is $0.22.

Telemedycyna Polska share price increased by 8.9% in the last 30 days, and by 37.5% in the last year.

Telemedycyna Polska has an EPS (earnings per share) of $-0.03.

See more trading valuation data for Telemedycyna Polska
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3M$3M8.9%8.9%57.7%37.5%$-0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Telemedycyna Polska Valuation Multiples

Telemedycyna Polska trades at 2.0x EV/Revenue multiple, and (9.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Telemedycyna Polska

Telemedycyna Polska Financial Valuation Multiples

As of June 2, 2026, Telemedycyna Polska has market cap of $3M and EV of $3M.

Telemedycyna Polska has a P/E ratio of (7.3x).

Last FY202320242025202620272028
EV/Revenue2.0x1.7x1.9x2.0x
EV/EBITDA(9.0x)(152.7x)(5.1x)(9.0x)
EV/EBIT(7.3x)(34.2x)(4.6x)(7.3x)
EV/Gross Profit2.2x1.7x2.2x2.2x
P/E(7.3x)(45.9x)(4.0x)(7.3x)
EV/FCF(16.6x)(14.0x)(6.1x)(16.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Telemedycyna Polska Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Telemedycyna Polska Margins & Growth Rates

In the most recent fiscal year, Telemedycyna Polska reported gross margin of 92%, EBITDA margin of (22%), and net margin of (28%).

See estimated margins and future growth rates for Telemedycyna Polska

Telemedycyna Polska Margins

Last FY20242025202720282029
Gross Margin92%89%92%
EBITDA Margin(22%)(38%)(22%)
EBIT Margin(27%)(42%)(27%)
Net Margin(28%)(50%)(28%)
FCF Margin(12%)(31%)(12%)

Telemedycyna Polska Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(12%)(3%)
Gross Profit Growth(20%)0%
EBITDA Growth2903%(43%)
EBIT Growth651%(38%)
Net Profit Growth1062%(46%)
FCF Growth129%(63%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Telemedycyna Polska Operational KPIs

Telemedycyna Polska's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Telemedycyna Polska
Last FY202320242025202620272028
Revenue per Employee$0.0M---
Opex per Employee$0.0M---
Opex to Revenue119%103%131%119%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Telemedycyna Polska Competitors

Telemedycyna Polska competitors include Aino Health, Andiamo, Monsenso, Medondo Holding, 1933 Industries, Alternate Health, Feedback, Brain Scientific, Ludwig Enterprises and Premier Health Of America.

Most Telemedycyna Polska public comparables operate across Health Data & Analytics, Healthcare Software, Telemedicine & Virtual Care, B2B SaaS, HealthTech and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aino Health1.1x-(11.9x)-
Andiamo----
Monsenso2.0x-(5.9x)-
Medondo Holding3.8x-(5.6x)-
1933 Industries1.0x-17.5x-
Alternate Health----
Feedback(0.3x)(0.3x)0.1x0.1x
Brain Scientific----

This data is available for Pro users. Sign up to see all Telemedycyna Polska competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Telemedycyna Polska

When was Telemedycyna Polska founded?Telemedycyna Polska was founded in 2005.
Where is Telemedycyna Polska headquartered?Telemedycyna Polska is headquartered in Poland.
How many employees does Telemedycyna Polska have?As of today, Telemedycyna Polska has over 35 employees.
Is Telemedycyna Polska publicly listed?Yes, Telemedycyna Polska is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Telemedycyna Polska?Telemedycyna Polska trades under TMP ticker.
When did Telemedycyna Polska go public?Telemedycyna Polska went public in 2010.
Who are competitors of Telemedycyna Polska?Telemedycyna Polska main competitors include Aino Health, Andiamo, Monsenso, Medondo Holding, 1933 Industries, Alternate Health, Feedback, Brain Scientific, Ludwig Enterprises, Premier Health Of America.
What is the current market cap of Telemedycyna Polska?Telemedycyna Polska's current market cap is $3M.
What is the current revenue of Telemedycyna Polska?Telemedycyna Polska's last fiscal year revenue is $1M.
What is the current EV/Revenue multiple of Telemedycyna Polska?Current revenue multiple of Telemedycyna Polska is 2.0x.
Is Telemedycyna Polska profitable?No, Telemedycyna Polska is not profitable.
How many companies Telemedycyna Polska has acquired to date?Telemedycyna Polska hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Telemedycyna Polska has invested to date?Telemedycyna Polska hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Telemedycyna Polska

Lists including Telemedycyna Polska

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial